Tofacitinib shown to be effective (vs Placebo) in 225 Polyarticular JIA (included some ERA & PsA). with less flares

Social Author Image

https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg

Tweet Author

Social Author Name

Dr. John Cush

Tweet Content

Tofacitinib shown to be effective (vs Placebo) in 225 Polyarticular JIA (included some ERA & PsA). with less flares (29 vs 53%) and higher JCR30 responses (71 vs 47%) @6mos #EULAR2020 #OP0281 https://t.co/3BnZeB4ROr https://t.co/4pTLbTtBdN

Links

https://j.mp/371aIyu

Show on Archive Page

On

Display in Search Results

On

Topics

Tofacitinib shown to be effective (vs Placebo) in 225 Polyarticular JIA (included some ERA & PsA). with less flares

Do you get our email newsletter?

Tofacitinib shown to be effective (vs Placebo) in 225 Polyarticular JIA (included some ERA &amp; PsA). with less flares

Tofacitinib shown to be effective (vs Placebo) in 225 Polyarticular JIA (included some ERA & PsA). with less flares